Skip to content

Evaluation of the curative effect of Chinese herbal medicine for external treatment of chloasma

Evaluation of the curative effect of Chinese herbal medicine for external treatment of chloasma

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084521
Enrollment
Unknown
Registered
2024-05-20
Start date
2022-08-08
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chloasma

Interventions

Test group:External use of traditional Chinese medicine

Sponsors

Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of Melasma in stable period; 2.Patients aged 20—60,regardless of gender.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lantating women; 2.Individuals with allergic constitution or allergic to this drug or its ingredients; 3.Having severe systemic diseases such as heart,kidey,liver,and endocrine systen,or suffering from tumors and immunodeiciency diseases; 4.Have taken medicationfor the treatment of this disease within the past 30 days (including drugs for promoting blood circulation and resolving biood stasis);And/or medication used to treat this disease within or after 7 days; 5.Pigmentation caused by other diseases; 6.Skin lesions such as Herpes simpiex,ulceration,immersion and erosion on the face,or sensitive skin diseases

Design outcomes

Primary

MeasureTime frame
Melasma area and severity;

Secondary

MeasureTime frame
The improvement of the number and morphology of blood vessels in the skin lesin before and after the treatment of chloasma;

Countries

China

Contacts

Public ContactFengyan Tian

Xiyuan Hospital,Chinese Academy of Traditional Chinese Medicine

yunhufeng@126.com+86 152 1018 7689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026